Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Chaperonins
Distributive justice and the arrival of direct-acting antivirals: who should be first in line?
Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Distributive justice and the arrival of direct-acting antivirals: who should be first in line?
Distributive justice and the arrival of direct-acting antivirals: who should be first in line? Hepatology. 2011 Jun; 53(6):1789-91.
View in:
PubMed
subject areas
Algorithms
Antiviral Agents
Health Care Rationing
Hepatitis C
Humans
Oligopeptides
Proline
Resource Allocation
United States
United States Food and Drug Administration
authors with profiles
Andrew Aronsohn